Literature DB >> 31002378

Prevalence of polycystic ovary syndrome in a metabolically healthy obese population.

Liangshan Mu1,2,3, Yue Zhao1,2,3, Rong Li1,2,3, Yuchen Lai1,2,3, Hsun-Ming Chang1,2,3, Jie Qiao1,2,3.   

Abstract

OBJECTIVE: To determine whether polycystic ovary syndrome (PCOS) prevalence is increased among metabolically healthy obese (MHO) women.
METHODS: A national epidemiologic survey in 10 provinces and municipalities of China between October 2007 and September 2011. Women were stratified into four groups according to metabolic health (assessment by Adult Treatment Panel III) and obesity (body mass index [BMI] ≥28): metabolically healthy nonobese (MHNO), metabolically unhealthy nonobese (MUNO), MHO, and metabolically unhealthy obese (MUO). PCOS was diagnosed via Rotterdam Criteria. Participants completed a questionnaire and underwent physical and transvaginal ultrasound examination. BMI, blood pressure, glucose, and lipid profile were measured.
RESULTS: The survey included 3551 women. The MHO group had a higher prevalence of PCOS and chronic anovulation versus nonobese groups (all P<0.05). Obesity was a risk factor for PCOS (odds ratio [OR], 2.30; 95% confidence interval [CI], 1.68-3.14, P<0.05). Being metabolically unhealthy was a risk factor for PCOS (OR, 1.32; 95% CI, 1.09-1.60; P<0.05). The MHO group had an increased risk of PCOS relative to the MHNO group (OR, 2.39; 95% CI, 1.42-4.02; P<0.05).
CONCLUSION: MHO women had an increased risk of PCOS and chronic anovulation. Obesity might be an independent risk factor for these two disorders.
© 2019 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Chronic anovulation; Dyslipidemia; Metabolic syndrome; Obesity; Polycystic ovary syndrome; Prevalence

Mesh:

Year:  2019        PMID: 31002378     DOI: 10.1002/ijgo.12824

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  5 in total

1.  Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.

Authors:  Jingjing Liu; Qunhong Wu; Yanhua Hao; Mingli Jiao; Xing Wang; Shengchao Jiang; Liyuan Han
Journal:  Hum Reprod       Date:  2021-03-18       Impact factor: 6.918

2.  The risk factors of gestational hypertension in patients with polycystic ovary syndrome: a retrospective analysis.

Authors:  Shu Zhou; Yiping Ji; Haimei Wang
Journal:  BMC Pregnancy Childbirth       Date:  2021-04-27       Impact factor: 3.007

3.  Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition.

Authors:  Luigi Barrea; Giovanna Muscogiuri; Gabriella Pugliese; Giulia de Alteriis; Annamaria Colao; Silvia Savastano
Journal:  Nutrients       Date:  2021-11-02       Impact factor: 5.717

4.  Effect of weight loss on pregnancy outcomes, neuronal-reproductive-metabolic hormones and gene expression profiles in granulosa cells in obese infertile PCOS patients undergoing IVF-ET.

Authors:  Limin Wu; Qunying Fang; Mengli Wang; Yurui Wang; Xinyi Zhu; Zhaohui Fang; Fangting Lu; Bo Xu; Rentao Jin; Hui Han; Xianhong Tong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-30       Impact factor: 6.055

5.  How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics.

Authors:  Xiaoxuan Zhao; Xiaoling Feng; Xinjie Zhao; Yuepeng Jiang; Xianna Li; Jingyun Niu; Xiaoyu Meng; Jing Wu; Guowang Xu; Lihui Hou; Ying Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-02       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.